Oncolytics Biotech
ONCY
#9621
Rank
โ‚ฌ88.95 M
Marketcap
0,75ย โ‚ฌ
Share price
2.50%
Change (1 day)
-26.37%
Change (1 year)

Oncolytics Biotech (ONCY) - Cash on Hand

Cash on Hand as of March 2026 : โ‚ฌ4.82 Million

According to Oncolytics Biotech 's latest financial reports the company has โ‚ฌ4.82 Million in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Oncolytics Biotech - Cash on Hand chart (from 2000 to 2026)

Cash on Hand by year

Year Cash on Hand Change
2025-12-31โ‚ฌ4.42 M-58.41%
2024-12-31โ‚ฌ10.64 M-55.28%
2023-12-31โ‚ฌ23.8 M7.84%
2022-12-31โ‚ฌ22.07 M-22.75%
2021-12-31โ‚ฌ28.57 M43.56%
2020-12-31โ‚ฌ19.9 M105.88%
2019-12-31โ‚ฌ9.66 M9.96%
2018-12-31โ‚ฌ8.79 M12.08%
2017-12-31โ‚ฌ7.84 M-21.47%
2016-12-31โ‚ฌ9.98 M-41.88%
2015-12-31โ‚ฌ17.18 M49.93%
2014-12-31โ‚ฌ11.46 M-38.08%
2013-12-31โ‚ฌ18.51 M14.41%
2012-12-31โ‚ฌ16.18 M-38.45%
2011-12-31โ‚ฌ26.28 M-18.49%
2010-12-31โ‚ฌ32.25 M41.77%
2009-12-31โ‚ฌ22.74 M191.53%
2008-12-31โ‚ฌ7.8 M-55.25%
2007-12-31โ‚ฌ17.43 M-2.88%
2006-12-31โ‚ฌ17.95 M-38.87%
2005-12-31โ‚ฌ29.36 M41.2%
2004-12-31โ‚ฌ20.8 M63.64%
2003-12-31โ‚ฌ12.71 M151.45%
2002-12-31โ‚ฌ5.05 M-52.53%
2001-12-31โ‚ฌ10.64 M-14.63%
2000-12-31โ‚ฌ12.47 M299.59%
1999-12-31โ‚ฌ3.12 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
Eli Lilly
LLY
โ‚ฌ4.64 B 96,058.75%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
โ‚ฌ9.21 B 190,797.51%๐Ÿ‡บ๐Ÿ‡ธ USA
Mirati Therapeutics
MRTX
โ‚ฌ0.85 B 17,675.97%๐Ÿ‡บ๐Ÿ‡ธ USA
Aeterna Zentaris
AEZS
โ‚ฌ24.42 M 406.17%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
โ‚ฌ3.28 B 68,004.86%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
AVEO Oncology
AVEO
โ‚ฌ68 M 1,309.03%๐Ÿ‡บ๐Ÿ‡ธ USA